Home World News Ovarian Function Suppression Plus Tamoxifen Significantly Reduces Premenopausal Breast Cancer Recurrence Over... World News Ovarian Function Suppression Plus Tamoxifen Significantly Reduces Premenopausal Breast Cancer Recurrence Over Tamoxifen and Further Reduction Is Seen When Combined with Exemestane By Ogkologos - July 6, 2026 140 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SOFT and TEXT studies Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR How to Find an Oncologist Who’s an LGBTQ+ Ally: An Expert... April 14, 2021 A Genome-Wide Association Study of irAEs Identifies New Genome-Wide Significant Associations... January 20, 2023 FDA Approves Cemiplimab-rwlc in Combination with Platinum-Based Chemotherapy for Advanced NSCLC November 25, 2022 New Immunotherapy Option Approved for Cervical Cancer, Rare Lymphoma August 2, 2018 Load more HOT NEWS VA Study Finds No Disparities in Prostate Cancer Deaths with Equal... FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof... Mortality From PSA-Detected Localised Prostate Cancer Remains Very Low Regardless of... HPV Vaccine May Provide Men with “Herd Immunity” against Oral HPV...
